Xtant Medical Holdings Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名45/208位。机构持股占比非常高,近一月多位分析师给出公司评级为强力买入。最高目标价1.50。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
Xtant Medical Holdings Inc评分
相关信息
行业排名
45 / 208
全市场排名
125 / 4582
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
2
位分析师
强力买入
评级
1.500
目标均价
+111.92%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Xtant Medical Holdings Inc亮点
亮点风险
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
公司代码XTNT
公司Xtant Medical Holdings Inc
CEOBrowne (Sean E)
网址https://xtantmedical.com/
常见问题
Xtant Medical Holdings Inc(XTNT)的当前股价是多少?
Xtant Medical Holdings Inc(XTNT)的当前股价是 0.797。
Xtant Medical Holdings Inc的股票代码是什么?
Xtant Medical Holdings Inc的股票代码是XTNT。
Xtant Medical Holdings Inc股票的52周最高点是多少?
Xtant Medical Holdings Inc股票的52周最高点是0.950。
Xtant Medical Holdings Inc股票的52周最低点是多少?
Xtant Medical Holdings Inc股票的52周最低点是0.340。
Xtant Medical Holdings Inc的市值是多少?
Xtant Medical Holdings Inc的市值是111.54M。
Xtant Medical Holdings Inc的净利润是多少?
Xtant Medical Holdings Inc的净利润为-16.45M。
现在Xtant Medical Holdings Inc(XTNT)的股票是买入、持有还是卖出?
根据分析师评级,Xtant Medical Holdings Inc(XTNT)的总体评级为--,目标价格为1.500。
Xtant Medical Holdings Inc(XTNT)股票的每股收益(EPS TTM)是多少
Xtant Medical Holdings Inc(XTNT)股票的每股收益(EPS TTM)是0.013。